Skip to main content
UniHealth

Doctor search

Helen W Shih, NP

Nurse Practitioner · Stanford

NPI 1750512240

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
17 years
Graduated 2009

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Helen W Shih’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A18938 · Deceased

Licence status: Deceased · since 1959 · University of Santo Tomas Faculty of Medicine and Surgery.

Licensee is deceased.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$18,214

Medicare paid this office $18,214 for 152 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)41$4,284$93
Long return visit (40+ min)31$4,176$123
Long return visit (40+ min)25$2,891$111
Short return visit (20+ min)29$2,136$65
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or13$865$24
See all 6 services
Every Original Medicare service billed
Return visit (30+ min)41$4,284$93
Long return visit (40+ min)31$4,176$123
Long return visit (40+ min)25$2,891$111
Short return visit (20+ min)29$2,136$65
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or13$865$24
Short return visit14$509$36

Who their Medicare patients are

152 Original Medicare patients in 2024. Average age 74 · Women 63% · Also on Medicaid 26% · Health risk score 2.27. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 74% · Cancer 38% · Diabetes 33% · Chronic kidney disease 29% · Coronary heart disease 28% · Heart failure 27% · Atrial fibrillation 18% · Depression 18% · Stroke 16% · COPD 13%.

The office billed $109,299, Medicare allowed $23,755 and paid $18,214; for 239 services of 8 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024152239742.27$109,299$18,214
202370116712.06$62,921$8,408
2022104126732.15$35,079$5,731
2021154235731.95$45,301$11,861
202058135722.70$93,377$9,278
201987247722.61$190,147$19,727
2018106271722.69$195,748$21,992
201789215732.43$133,249$15,934
20151391,074771.94$38,198$7,153
20141612,255771.66$136,068$23,722
20131562,402781.65$154,113$27,890

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Long return visit (40+ min)33$3,977$110
Return visit (30+ min)25$2,149$74
Short return visit (20+ min)18$1,037$52

2022: 4 services

Original Medicare services billed in 2022
Long return visit (40+ min)12$1,455$112
Short return visit (20+ min)12$580$48
Short return visit37$472$12
Short return visit13$231$18

2021: 4 services

Original Medicare services billed in 2021
Short return visit (20+ min)75$4,789$53
Return visit (30+ min)28$2,234$80
Short return visit58$1,828$26
Short return visit (20+ min)11$564$47

2020: 2 services

Original Medicare services billed in 2020
Long return visit (40+ min)50$7,270$75
Return visit (30+ min)22$1,710$59

2019: 1 service

Original Medicare services billed in 2019
Long return visit (40+ min)85$19,489$80

2018: 2 services

Original Medicare services billed in 2018
Long return visit (40+ min)103$21,101$82
Return visit (30+ min)11$891$59

2017: 2 services

Original Medicare services billed in 2017
Long return visit (40+ min)65$10,815$84
Return visit (30+ min)48$4,964$60

2015: 3 services

Original Medicare services billed in 2015
Blood test, clotting time139$4,962$5
Office for the evaluation and management of established patient that may not require presence of healthcare professional71$1,293$12
Short return visit11$400$33

2014: 5 services

Original Medicare services billed in 2014
Office for the evaluation and management of established patient that may not require presence of healthcare professional141$8,335$13
Blood test, clotting time158$7,506$5
Short return visit70$4,254$36
Short return visit (20+ min)27$1,932$59
New patient visit (15+ min)16$849$53

2013: 3 services

Original Medicare services billed in 2013
Office for the evaluation and management of established patient that may not require presence of healthcare professional148$19,715$17
Blood test, clotting time146$6,272$5
New patient visit (15+ min)32$1,867$58

Drugs they prescribed that Part D paid

$1,533

Pharmacies billed $1,533 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

38 generic and fewer than 11 brand-name prescriptions · $1,533 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Levothyroxine25$972$39

Year by year

Part D prescribing by year
20244420NoneNone$1,533
2023814115% (12)None$4,136
20221023512% (12)None$2,972
202110645None42%$341,847
20204911056% (28)None$2,278,244
20195201219% (45)34%$1,582,315
20184789814% (65)31%$1,202,895
201754110516% (84)None$1,697,922
201634210019% (66)18%$342,008
20153931046% (24)None$9,828
201430686NoneNone$5,275
2013277740% (0)None$6,635

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 2 drugs

Part D drugs prescribed in 2023
Levothyroxine14$284$20
Ondansetron13$265$20

2022: 3 drugs

Part D drugs prescribed in 2022
Levothyroxine29$524$18
Potassium Chloride17$302$18
Spironolactone12$101$8

2020: 15 drugs

Part D drugs prescribed in 2020
Tagrisso73$1,161,051$15,905
Xalkori32$594,072$18,565
Alecensa11$169,696$15,427
Xarelto23$17,015$740
Enoxaparin28$16,429$587
Eliquis18$8,937$497
Entecavir11$1,250$114
Scopolamine11$1,244$113
Potassium Chloride32$1,001$31
Prochlorperazine Maleate29$540$19
Losartan20$298$15
Levothyroxine16$295$18
Ondansetron12$172$14
Lorazepam14$38$3
Amlodipine Besylate11$37$3

2019: 14 drugs

Part D drugs prescribed in 2019
Tagrisso75$1,187,198$15,829
Xalkori11$193,394$17,581
Enoxaparin32$17,985$562
Xarelto11$5,674$516
Potassium Chloride25$922$37
Hydrocodone-Acetaminophen23$515$22
Dexamethasone11$443$40
Prochlorperazine Maleate16$244$15
Mirtazapine21$241$11
Triamcinolone Acetonide15$232$15
Ondansetron12$223$19
Oxycodone11$191$17
Lorazepam25$134$5
Losartan16$121$8

2018: 11 drugs

Part D drugs prescribed in 2018
Tagrisso45$687,877$15,286
Enoxaparin33$15,407$467
Hydrocodone-Acetaminophen29$1,093$38
Triamcinolone Acetonide26$722$28
Synthroid12$437$36
Oxycodone15$384$26
Ondansetron21$344$16
Gabapentin12$185$15
Prochlorperazine Maleate12$150$13
Mirtazapine25$150$6
Lorazepam19$78$4

2017: 16 drugs

Part D drugs prescribed in 2017
Tagrisso62$952,841$15,368
Tarceva15$203,556$13,570
Nexavar11$184,687$16,790
Alecensa11$158,188$14,381
Enoxaparin16$13,170$823
Morphine Sulfate Er17$708$42
Oxycodone18$707$39
Hydrocodone-Acetaminophen23$623$27
Triamcinolone Acetonide17$430$25
Mirtazapine38$409$11
Gabapentin17$296$17
Lorazepam37$253$7
Dexamethasone21$213$10
Ondansetron15$141$9
Prochlorperazine Maleate15$97$6
Zolpidem11$86$8

2016: 8 drugs

Part D drugs prescribed in 2016
Tarceva13$87,655$6,743
Warfarin51$1,180$23
Hydrocodone-Acetaminophen14$823$59
Triamcinolone Acetonide25$685$27
Morphine Sulfate Er14$587$42
Oxycodone15$526$35
Lorazepam24$161$7
Mirtazapine19$151$8

2015: 1 drug

Part D drugs prescribed in 2015
Warfarin357$7,754$22

2014: 1 drug

Part D drugs prescribed in 2014
Warfarin297$4,539$15

2013: 3 drugs

Part D drugs prescribed in 2013
Warfarin175$3,035$17
Benazepril12$217$18
Simvastatin13$88$7

Money from drug and device companies

$31,613 in 2025

Industry payments by year
20251066$23,701$31,613
2024953$10,819$17,020
2023855$12,750$23,158
2022430$8,450$14,956
20211246$12,435$17,745

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
E.R. Squibb & Sons L.L.C.Opdivo$21,826
29 payments
  • Meals for Opdivo · 2025-11-20 · $20
  • Paid to speak or teach for Opdivo · 2025-11-18 · $2,520
  • Meals for Opdivo · 2025-10-29 · $113
  • Travel for Opdivo · 2025-10-29 · $1,106
  • Travel for Opdivo · 2025-10-08 · $266
  • Paid to speak or teach for Opdivo · 2025-09-29 · $1,960
  • Meals for Opdivo · 2025-09-23 · $1
  • Consulting · 2025-09-17 · $140
  • Meals for Opdivo · 2025-09-09 · $122
  • Consulting · 2025-07-15 · $140
  • Travel for Opdivo · 2025-05-07 · $63
  • Paid to speak or teach for Opdivo · 2025-04-29 · $1,960
  • Meals for Opdivo · 2025-04-25 · $38
  • Paid to speak or teach for Opdivo · 2025-04-25 · $2,520
  • Meals for Opdivo · 2025-04-17 · $133
  • Travel for Opdivo · 2025-04-08 · $1,238
  • Meals for Opdivo · 2025-04-08 · $108
  • Paid to speak or teach for Opdivo · 2025-03-14 · $1,540
  • Paid to speak or teach for Opdivo · 2025-03-11 · $1,960
  • Travel for Opdivo · 2025-03-06 · $145
  • Paid to speak or teach for Opdivo · 2025-03-06 · $1,960
  • Travel for Opdivo · 2025-02-28 · $179
  • Consulting · 2025-02-25 · $560
  • Consulting · 2025-02-25 · $560
  • Meals for Opdivo · 2025-02-18 · $124
  • Meals for Opdivo · 2025-02-11 · $128
  • Meals for Opdivo · 2025-01-21 · $206
  • Travel for Opdivo · 2025-01-21 · $138
  • Paid to speak or teach for Opdivo · 2025-01-16 · $1,881
AstraZeneca Pharmaceuticals LPCalquence$9,352
19 payments
  • Meals for Calquence · 2025-12-22 · $26
  • Travel · 2025-10-22 · $288
  • Travel · 2025-10-16 · $199
  • Meals · 2025-10-16 · $90
  • Meals · 2025-10-16 · $100
  • Paid to speak or teach · 2025-10-15 · $2,400
  • Travel · 2025-10-10 · $1,002
  • Meals · 2025-10-10 · $128
  • Travel · 2025-10-10 · $479
  • Meals for Calquence · 2025-10-07 · $25
  • Paid to speak or teach · 2025-09-29 · $600
  • Meals for Calquence · 2025-08-13 · $23
  • Travel · 2025-08-07 · $14
  • Paid to speak or teach · 2025-08-01 · $1,200
  • Meals · 2025-07-16 · $132
  • Meals for Calquence · 2025-05-17 · $21
  • Paid to speak or teach · 2025-05-12 · $1,800
  • Travel · 2025-04-29 · $701
  • Meals · 2025-04-29 · $124
Merck Sharp & DohmeKeytruda$180
6 payments
  • Meals for Keytruda · 2025-10-14 · $27
  • Meals for Keytruda · 2025-09-23 · $33
  • Meals for Keytruda · 2025-07-25 · $31
  • Meals for Keytruda · 2025-07-08 · $30
  • Meals for Welireg · 2025-01-31 · $28
  • Meals for Keytruda · 2025-01-24 · $31
Daiichi SankyoVanflyta$58
2 payments
  • Meals for Vanflyta · 2025-11-12 · $29
  • Meals for Vanflyta · 2025-07-31 · $29
Rigel PharmaceuticalsTavalisse$49
2 payments
  • Meals for Tavalisse · 2025-09-22 · $30
  • Meals for Tavalisse · 2025-09-22 · $19
Agios PharmaceuticalsPyrukynd$35
1 payment
  • Meals for Pyrukynd · 2025-09-19 · $35
See all 63 published payments
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-12-22Calquence$26
E.R. Squibb & Sons L.L.C.Meals · 2025-11-20Opdivo$20
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-11-18Opdivo$2,520
Takeda Pharmaceuticals U.S.A.Meals · 2025-11-18Vonvendi$30
Daiichi SankyoMeals · 2025-11-12Vanflyta$29
Kite PharmaMeals · 2025-11-11Yescarta$31
E.R. Squibb & Sons L.L.C.Meals · 2025-10-29Opdivo$113
E.R. Squibb & Sons L.L.C.Travel · 2025-10-29Opdivo$1,106
AstraZeneca Pharmaceuticals LPTravel · 2025-10-22None$288
AstraZeneca Pharmaceuticals LPTravel · 2025-10-16None$199
AstraZeneca Pharmaceuticals LPMeals · 2025-10-16None$90
AstraZeneca Pharmaceuticals LPMeals · 2025-10-16None$100
AstraZeneca Pharmaceuticals LPPaid to speak or teach · 2025-10-15None$2,400
Merck Sharp & DohmeMeals · 2025-10-14Keytruda$27
AstraZeneca Pharmaceuticals LPTravel · 2025-10-10None$1,002
AstraZeneca Pharmaceuticals LPMeals · 2025-10-10None$128
AstraZeneca Pharmaceuticals LPTravel · 2025-10-10None$479
E.R. Squibb & Sons L.L.C.Travel · 2025-10-08Opdivo$266
CelgeneMeals · 2025-10-07Reblozyl$18
AstraZeneca Pharmaceuticals LPMeals · 2025-10-07Calquence$25
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-09-29Opdivo$1,960
AstraZeneca Pharmaceuticals LPPaid to speak or teach · 2025-09-29None$600
E.R. Squibb & Sons L.L.C.Meals · 2025-09-23Opdivo$1
Merck Sharp & DohmeMeals · 2025-09-23Keytruda$33
Rigel PharmaceuticalsMeals · 2025-09-22Tavalisse$30
Rigel PharmaceuticalsMeals · 2025-09-22Tavalisse$19
Agios PharmaceuticalsMeals · 2025-09-19Pyrukynd$35
E.R. Squibb & Sons L.L.C.Consulting · 2025-09-17None$140
E.R. Squibb & Sons L.L.C.Meals · 2025-09-09Opdivo$122
AstraZeneca Pharmaceuticals LPMeals · 2025-08-13Calquence$23
AstraZeneca Pharmaceuticals LPTravel · 2025-08-07None$14
AstraZeneca Pharmaceuticals LPPaid to speak or teach · 2025-08-01None$1,200
Daiichi SankyoMeals · 2025-07-31Vanflyta$29
Merck Sharp & DohmeMeals · 2025-07-25Keytruda$31
AstraZeneca Pharmaceuticals LPMeals · 2025-07-16None$132
E.R. Squibb & Sons L.L.C.Consulting · 2025-07-15None$140
Merck Sharp & DohmeMeals · 2025-07-08Keytruda$30
AstraZeneca Pharmaceuticals LPMeals · 2025-05-17Calquence$21
AstraZeneca Pharmaceuticals LPPaid to speak or teach · 2025-05-12None$1,800
E.R. Squibb & Sons L.L.C.Travel · 2025-05-07Opdivo$63
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-04-29Opdivo$1,960
AstraZeneca Pharmaceuticals LPTravel · 2025-04-29None$701
AstraZeneca Pharmaceuticals LPMeals · 2025-04-29None$124
E.R. Squibb & Sons L.L.C.Meals · 2025-04-25Opdivo$38
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-04-25Opdivo$2,520
E.R. Squibb & Sons L.L.C.Meals · 2025-04-17Opdivo$133
E.R. Squibb & Sons L.L.C.Travel · 2025-04-08Opdivo$1,238
E.R. Squibb & Sons L.L.C.Meals · 2025-04-08Opdivo$108
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-03-14Opdivo$1,540
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-03-11Opdivo$1,960
E.R. Squibb & Sons L.L.C.Travel · 2025-03-06Opdivo$145
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-03-06Opdivo$1,960
E.R. Squibb & Sons L.L.C.Travel · 2025-02-28Opdivo$179
E.R. Squibb & Sons L.L.C.Consulting · 2025-02-25None$560
E.R. Squibb & Sons L.L.C.Consulting · 2025-02-25None$560
E.R. Squibb & Sons L.L.C.Meals · 2025-02-18Opdivo$124
E.R. Squibb & Sons L.L.C.Meals · 2025-02-11Opdivo$128
Merck Sharp & DohmeMeals · 2025-01-31Welireg$28
Merck Sharp & DohmeMeals · 2025-01-24Keytruda$31
E.R. Squibb & Sons L.L.C.Meals · 2025-01-21Opdivo$206
E.R. Squibb & Sons L.L.C.Travel · 2025-01-21Opdivo$138
E.R. Squibb & Sons L.L.C.Paid to speak or teach · 2025-01-16Opdivo$1,881
Lilly USAMeals · 2025-01-02None$34
See earlier years (2024, 2023, 2022, 2021)

2024: $17,020

Payments by company in 2024
E.R. Squibb & Sons L.L.C.Opdivo$11,230
22 payments
  • Travel for Opdivo · 2024-11-16 · $375
  • Travel for Opdivo · 2024-11-16 · $331
  • Travel for Opdivo · 2024-11-16 · $465
  • Meals for Opdivo · 2024-10-29 · $18
  • Meals for Opdivo · 2024-10-29 · $7
  • Consulting · 2024-10-10 · $600
  • Meals for Opdivo · 2024-07-19 · $82
  • Travel for Opdivo · 2024-07-19 · $35
  • Travel for Opdivo · 2024-07-19 · $207
  • Paid to speak or teach for Opdivo · 2024-07-02 · $1,881
  • Paid to speak or teach for Opdivo · 2024-06-18 · $798
  • Consulting · 2024-06-18 · $600
  • Travel for Opdivo · 2024-06-13 · $1,426
  • Travel for Opdivo · 2024-06-13 · $9
  • Meals for Opdivo · 2024-06-13 · $115
  • Paid to speak or teach for Opdivo · 2024-06-05 · $1,881
  • Travel for Opdivo · 2024-05-16 · $722
  • Travel for Opdivo · 2024-05-16 · $439
  • Meals for Opdivo · 2024-05-16 · $88
  • Travel for Opdivo · 2024-05-16 · $371
  • Travel for Opdivo · 2024-01-04 · $93
  • Paid to speak or teach for Opdivo · 2024-01-04 · $684
Lilly USAVerzenio$4,876
16 payments
  • Meals for Verzenio · 2024-11-12 · $8
  • Meals for Verzenio · 2024-11-12 · $20
  • Meals for Verzenio · 2024-09-18 · $30
  • Paid to speak or teach · 2024-08-28 · $225
  • Meals for Verzenio · 2024-08-24 · $21
  • Paid to speak or teach · 2024-08-16 · $1,200
  • Paid to speak or teach · 2024-08-16 · $450
  • Travel · 2024-08-12 · $662
  • Meals · 2024-08-12 · $98
  • Meals · 2024-04-06 · $37
  • Paid to speak or teach · 2024-02-05 · $150
  • Travel · 2024-01-23 · $51
  • Paid to speak or teach · 2024-01-23 · $150
  • Paid to speak or teach · 2024-01-23 · $450
  • Paid to speak or teach · 2024-01-23 · $1,200
  • Meals · 2024-01-18 · $124
AstraZeneca Pharmaceuticals LPTagrisso$668
6 payments
  • Meals for Calquence · 2024-12-24 · $29
  • Paid to speak or teach for Tagrisso · 2024-12-03 · $250
  • Meals for Calquence · 2024-11-25 · $28
  • Meals for Calquence · 2024-09-24 · $31
  • Meals · 2024-08-28 · $29
  • Paid to speak or teach for Tagrisso · 2024-03-07 · $300
Merck Sharp & DohmeKeytruda$83
3 payments
  • Meals for Keytruda · 2024-10-25 · $31
  • Meals for Keytruda · 2024-09-10 · $29
  • Meals for Keytruda · 2024-07-12 · $23
AbbvieEpkinly$55
2 payments
  • Meals for Imbruvica · 2024-08-21 · $20
  • Meals for Epkinly · 2024-08-20 · $34
Janssen BiotechDarzalex$36
1 payment
  • Meals for Darzalex · 2024-08-27 · $36
Ipsen BiopharmaceuticalsOnivyde$33
1 payment
  • Meals for Onivyde · 2024-05-01 · $33
Rigel PharmaceuticalsRezlidhia$21
1 payment
  • Meals for Rezlidhia · 2024-06-26 · $21
IncyteJakafi$18
1 payment
  • Meals for Jakafi · 2024-05-25 · $18

2023: $23,158

Payments by company in 2023
Lilly USANone$12,077
28 payments
  • Meals · 2023-12-18 · $125
  • Paid to speak or teach · 2023-11-07 · $1,200
  • Meals · 2023-11-07 · $27
  • Paid to speak or teach · 2023-11-07 · $750
  • Travel · 2023-11-02 · $646
  • Meals · 2023-11-02 · $36
  • Meals · 2023-11-02 · $29
  • Meals · 2023-08-04 · $35
  • Meals · 2023-08-04 · $50
  • Meals · 2023-08-04 · $19
  • Travel · 2023-08-04 · $55
  • Meals · 2023-07-31 · $11
  • Meals · 2023-07-31 · $37
  • Meals · 2023-07-31 · $35
  • Meals · 2023-07-21 · $45
  • Paid to speak or teach · 2023-07-18 · $1,200
  • Paid to speak or teach · 2023-07-18 · $1,200
  • Paid to speak or teach · 2023-07-18 · $1,050
  • Paid to speak or teach · 2023-07-18 · $1,050
  • Meals · 2023-07-13 · $111
  • Travel · 2023-07-12 · $167
  • Travel · 2023-07-12 · $1,233
  • Travel · 2023-07-12 · $1,300
  • Travel · 2023-07-12 · $749
  • Meals · 2023-07-12 · $79
  • Travel · 2023-07-12 · $170
  • Travel · 2023-07-12 · $369
  • Paid to speak or teach · 2023-05-31 · $300
Merck Sharp & DohmeKeytruda$9,267
18 payments
  • Paid to speak or teach for Keytruda · 2023-12-20 · $1,500
  • Travel for Keytruda · 2023-11-15 · $150
  • Travel for Keytruda · 2023-11-09 · $1,113
  • Meals for Keytruda · 2023-11-09 · $50
  • Meals for Keytruda · 2023-10-24 · $29
  • Meals for Keytruda · 2023-10-12 · $18
  • Paid to speak or teach for Keytruda · 2023-09-27 · $1,500
  • Travel for Keytruda · 2023-08-18 · $150
  • Travel for Keytruda · 2023-08-17 · $1,162
  • Meals for Keytruda · 2023-08-17 · $94
  • Travel for Keytruda · 2023-07-08 · $216
  • Paid to speak or teach for Keytruda · 2023-04-28 · $1,500
  • Travel for Keytruda · 2023-04-26 · $150
  • Travel for Keytruda · 2023-03-23 · $521
  • Travel for Keytruda · 2023-03-23 · $376
  • Meals for Keytruda · 2023-03-23 · $106
  • Travel for Keytruda · 2023-03-23 · $615
  • Meals for Keytruda · 2023-01-31 · $17
E.R. Squibb & Sons L.L.C.Opdivo$1,334
4 payments
  • Consulting · 2023-12-29 · $600
  • Meals for Opdivo · 2023-11-30 · $134
  • Consulting · 2023-10-05 · $300
  • Consulting · 2023-06-21 · $300
AstraZeneca Pharmaceuticals LPImfinzi$300
1 payment
  • Paid to speak or teach for Imfinzi · 2023-10-03 · $300
Bayer Healthcare PharmaceuticalsVitrakvi$97
1 payment
  • Meals for Vitrakvi · 2023-02-10 · $97
Blueprint MedicinesAyvakit$38
1 payment
  • Meals for Ayvakit · 2023-06-20 · $38
EisaiLenvima$23
1 payment
  • Meals for Lenvima · 2023-08-31 · $23
Pharmacyclics LLC An AbbVieImbruvica$21
1 payment
  • Meals for Imbruvica · 2023-01-18 · $21

2022: $14,956

Payments by company in 2022
AstraZeneca Pharmaceuticals LPImfinzi$10,264
17 payments
  • Paid to speak or teach for Imfinzi · 2022-12-05 · $450
  • Meals · 2022-11-10 · $135
  • Paid to speak or teach for Imfinzi · 2022-06-09 · $450
  • Travel for Tagrisso · 2022-04-30 · $154
  • Paid to speak or teach for Imfinzi · 2022-04-21 · $2,000
  • Meals for Imfinzi · 2022-04-11 · $39
  • Meals for Imfinzi · 2022-04-11 · $170
  • Travel for Imfinzi · 2022-04-11 · $15
  • Travel for Imfinzi · 2022-04-11 · $234
  • Travel for Imfinzi · 2022-04-11 · $1,923
  • Paid to speak or teach for Imfinzi · 2022-03-24 · $2,000
  • Travel for Imfinzi · 2022-03-18 · $15
  • Meals for Imfinzi · 2022-03-18 · $115
  • Meals for Imfinzi · 2022-03-18 · $146
  • Travel for Imfinzi · 2022-03-18 · $1,923
  • Travel for Imfinzi · 2022-03-18 · $245
  • Paid to speak or teach for Imfinzi · 2022-02-01 · $250
Merck Sharp & DohmeKeytruda$2,733
7 payments
  • Paid to speak or teach for Keytruda · 2022-10-26 · $1,500
  • Travel for Keytruda · 2022-10-21 · $75
  • Meals for Keytruda · 2022-10-14 · $15
  • Travel for Keytruda · 2022-09-26 · $998
  • Meals for Keytruda · 2022-09-26 · $104
  • Meals for Keytruda · 2022-09-07 · $19
  • Meals for Keytruda · 2022-05-17 · $22
E.R. Squibb & Sons L.L.C.Opdivo$1,941
5 payments
  • Paid to speak or teach for Opdivo · 2022-12-20 · $1,200
  • Travel for Opdivo · 2022-12-13 · $47
  • Meals for Opdivo · 2022-11-16 · $94
  • Consulting · 2022-04-28 · $300
  • Consulting · 2022-04-13 · $300
Pharmacyclics LLC an AbbVieImbruvica$19
1 payment
  • Meals for Imbruvica · 2022-11-18 · $19

2021: $17,745

Payments by company in 2021
AstraZeneca Pharmaceuticals LPTagrisso$13,061
25 payments
  • Paid to speak or teach for Tagrisso · 2021-12-14 · $250
  • Paid to speak or teach for Tagrisso · 2021-12-12 · $2,000
  • Travel for Tagrisso · 2021-12-08 · $0
  • Travel for Tagrisso · 2021-12-08 · $172
  • Travel for Tagrisso · 2021-12-08 · $191
  • Meals for Tagrisso · 2021-12-08 · $125
  • Meals for Tagrisso · 2021-12-08 · $161
  • Travel for Tagrisso · 2021-12-08 · $321
  • Paid to speak or teach for Imfinzi · 2021-10-10 · $450
  • Paid to speak or teach for Imfinzi · 2021-09-19 · $2,000
  • Meals for Imfinzi · 2021-09-09 · $84
  • Meals for Imfinzi · 2021-09-09 · $200
  • Travel for Imfinzi · 2021-09-09 · $1,213
  • Travel for Imfinzi · 2021-09-09 · $194
  • Travel for Imfinzi · 2021-09-09 · $145
  • Meals · 2021-08-26 · $44
  • Paid to speak or teach for Tagrisso · 2021-07-15 · $500
  • Paid to speak or teach for Imfinzi · 2021-06-22 · $450
  • Paid to speak or teach for Tagrisso · 2021-05-11 · $2,000
  • Meals for Tagrisso · 2021-05-06 · $98
  • Meals for Tagrisso · 2021-05-06 · $35
  • Travel for Tagrisso · 2021-05-06 · $1,128
  • Paid to speak or teach for Tagrisso · 2021-03-31 · $500
  • Paid to speak or teach for Tagrisso · 2021-03-08 · $500
  • Paid to speak or teach for Tagrisso · 2021-01-06 · $300
E.R. Squibb & Sons L.L.C.Opdivo$3,445
7 payments
  • Paid to speak or teach for Opdivo · 2021-09-14 · $1,200
  • Travel for Opdivo · 2021-08-31 · $365
  • Meals for Opdivo · 2021-08-31 · $112
  • Paid to speak or teach for Opdivo · 2021-07-13 · $1,200
  • Travel for Opdivo · 2021-07-06 · $82
  • Meals for Opdivo · 2021-06-15 · $151
  • Paid to speak or teach for Opdivo · 2021-04-08 · $335
Blueprint MedicinesGavreto$750
3 payments
  • Honoraria for Gavreto · 2021-06-23 · $150
  • Honoraria for Gavreto · 2021-06-09 · $300
  • Honoraria for Gavreto · 2021-02-12 · $300
Takeda Pharmaceuticals U.S.A.Exkivity$235
2 payments
  • Meals for Exkivity · 2021-12-14 · $118
  • Meals for Exkivity · 2021-12-14 · $118
GlaxoSmithKlineBlenrep$109
1 payment
  • Meals for Blenrep · 2021-04-29 · $109
PfizerXtandi$41
2 payments
  • Meals for Xtandi · 2021-12-14 · $25
  • Meals for Xtandi · 2021-07-30 · $16
Novartis PharmaceuticalsTasigna$22
1 payment
  • Meals for Tasigna · 2021-10-20 · $22
Merck Sharp & DohmeKeytruda$20
1 payment
  • Meals for Keytruda · 2021-10-21 · $20
AmgenNplate$18
1 payment
  • Meals for Nplate · 2021-12-21 · $18
Astellas Pharma USPadcev$16
1 payment
  • Meals for Padcev · 2021-09-22 · $16
Janssen BiotechImbruvica$15
1 payment
  • Meals for Imbruvica · 2021-11-17 · $15
TerSera TherapeuticsXermelo$14
1 payment
  • Meals for Xermelo · 2021-08-26 · $14

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1750512240
Licence
CA 18938California A18938: Deceased
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2009-07-31
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 234 Eddy St, San Francisco, CA, 94102